Roth Capital Starts Recro Pharma (REPH) at Buy
Tweet
Share
E-mailGet Alerts REPH Hot Sheet
Price: $2.09 --0%
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Roth Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.
Shares of Recro Pharma closed at $9.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Dollarama Inc. (DOL:CN) (DLMAF) at Buy
- Hovde Group Resumes Hancock Whitney (HWC) at Market Perform
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
